Yoğun Bakım Ünitesinde Beyin Ölümü Tanısı ve Donör Bakımı
Özet
Organ nakli bekleyen hasta sayısındaki artış ve bağış oranlarının yetersizliği, yoğun bakım ünitelerinde beyin ölümü (BÖ) tanısının hızlı konulmasını ve donör bakımının optimize edilmesini kritik hale getirmiştir. Beyin ölümü, tüm beyin, beyin sapı ve serebellar fonksiyonların tam ve geri dönüşümsüz kaybı olarak tanımlanır ve Türkiye'de iki uzman hekimin oy birliği ile karara bağlanır. Tanı; koma hali, beyin sapı reflekslerinin yokluğu ve pozitif apne testi olmak üzere üç temel kriterle konulur; şüpheli durumlarda ise serebral anjiyografi gibi destekleyici testlere başvurulur. Beyin ölümü sonrası gelişen "katekolamin fırtınası" ve ardından gelen vazodilatasyon süreçleri, organ kalitesini korumak adına titiz bir yönetim gerektirir. Donör bakımında temel hedef, "100’ler Kuralı" çerçevesinde hemodinamik stabiliteyi sağlamak, organ perfüzyonunu korumak ve diyabetes insipitus gibi komplikasyonları yönetmektir. Bu amaçla agresif sıvı replasmanı, vazoaktif ajanlar ve hormon replasman tedavileri (vazopressin, tiroid hormonları, kortikosteroidler) uygulanır. Ayrıca akciğer koruyucu ventilasyon stratejileri, elektrolit dengesi ve normoterminin korunması greft sağkalımı için elzemdir. Sonuç olarak, multidisipliner bir yaklaşımla yürütülen etkin donör yönetimi, nakledilen organ sayısını ve kalitesini artırarak bekleme listelerindeki ölüm oranlarını azaltma potansiyeline sahiptir.
The increasing number of patients awaiting organ transplantation and the insufficiency of donation rates have made the rapid diagnosis of brain death (BD) and the optimization of donor care in intensive care units critical. Brain death is defined as the complete and irreversible loss of all brain, brainstem, and cerebellar functions, and in Turkey, it is decided unanimously by two specialist physicians. The diagnosis is based on three main criteria: coma, absence of brainstem reflexes, and a positive apnea test; in suspicious cases, supportive tests such as cerebral angiography are utilized. The "catecholamine storm" following brain death and the subsequent vasodilation processes require meticulous management to preserve organ quality. The primary goal in donor care is to maintain hemodynamic stability and manage complications like diabetes insipidus within the framework of the "Rule of 100s". To this end, aggressive fluid resuscitation, vasoactive agents, and hormone replacement therapies (vasopressin, thyroid hormones, corticosteroids) are administered. Additionally, lung-protective ventilation strategies, electrolyte balance, and maintenance of normothermia are essential for graft survival. In conclusion, effective donor management carried out with a multidisciplinary approach has the potential to increase the number and quality of transplanted organs, thereby reducing mortality rates on waiting lists.
Referanslar
Transplant activity in the UK Activity report 2016/2017. NHS Blood and Transplant. http://www.uktransplant.org.uk/ (accessed 1 November 2017).
Citerio G, Cypel M, Dobb GJ, et al. Organ donation in adults: a critical care perspective. Intensive Care Medicine. 2016 Mar;42(3):305-315. doi: 10.1007/s00134-015-4191-5
Global observatory on donation and transplantation. Organ donation and transplantation: activities, laws and organization, http://www.transplant-observatory.org (accessed 30 September 2021).
Meyfroidt G, Gunst J, Martin -Loeches I, et al. Management of the brain-dead donor in the ICU: general and specific therapy to improve transplantable organ quality. Intensive Care Medicine. 2019 Mar;45(3):343-353. doi: 10.1007/s00134-019-05551-y
Wijdicks EFM, editor. Brain Death. Philadelphia: Lippincott Williams & Wilkins; 2001.
De Georgia M.A. History of brain death as death: 1968 to the present. Journal of Critical Care. 2014;29 (4):673-8. doi:10.1016/ j.jcrc.2014.04.015
American Academy of Neurology (AAN). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Practice parameters for determining brain death in adults. Neurology. 1995;45 (5):1012-1014. doi:10.1212/wnl.45.5.1012
Wijdicks EFM, Varelas PN, Gronseth GS, et al. Evidence-based guideline update: determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurulogy. Neurology.2010;74 (23):1911-1918. doi:10.1212/WNL.0b013e3181e242a8
Wahlster S, Wijdicks EF, Patel PV, et al. Brain death declaration: Practices and perceptions worldwide. Neurology. 2015;84 (18):1870-1879. doi:10.1212/WNL.0000000000001540
Escudero Augusto D. Brain death diagnosis. Medicina Intensiva 2009;33(4):185-195. doi:10.1016/s0210-5691(09)71215-x
Türk Nöroloji Derneği-Beyin Ölümü Tanı Kılavuzu. Türk Nöroloji Dergisi 20 (3):101-104, Şubat 2014.
Greer DM, Shemie SD, Lewis A, et al. Determination of brain death/death by neurologic criteria. JAMA. 2020 Sep 15;324(11):1078-1097. doi:10.1001/jama.2020.11586
Organ ve Doku Alınması Saklanması ve Nakli Hakkında Kanun (29.05.1979 Sayısı: 2238 R.G. Tarihi: 03.06.1979 R.G. Sayısı:16655)
Sağlık Bakanlığı Organ ve Doku Nakli Hizmetleri Yönetmeliği (Resmi Gazete: 01.02.2012 - 28191) Ek-1
Westphal GA, Robinson CC, Cavalcanti AB, et al. Brazilian guidelines for the management of brain-dead potential organ donors. The task force of the AMIB, ABTO, BRICNet, and the General Coordination of the National Transplant System. Annals of Intensive Care. 2020 Dec 14;10(1):169. doi:10.1186/s13613-020-00787-0
Kotloff RM, Blosser S, Fulda GJ, et al; Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Donor Management Task Force. Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement. Critical Care Medicine. 2015 Jun;43(6):1291-1325. doi:10.1097/CCM.0000000000000958
Fleming G, Thomson EM, Organ donation and management of the potential organ donor, Anaesthesia and intensive care medicine. 2021; 22(8): 475-481. doi.org/10.1016/j.mpaic.2021.06.007
Patel MS, Abt PL. Current practices in deceased organ donor management. Current Opinion in Organ Transplantation. 2019 Jun;24(3):343-350. doi:10.1097/MOT.0000000000000638
Ball IM, Hornby L, Rochwerg B, et al. Management of the neurologically deceased organ donor: A Canadian clinical practice guideline. Canadian Medical Association journal . 2020 Apr 6;192(14): E361-E369. doi:10.1503/cmaj.190631
NSW Government, Ministry of health. Management of the Adult Brain Dead Potential Organ and Tissue Donorhttps://www1.health.nsw.gov.au/pds/ActivePDSDocuments/GL2016_008.pdf/ Management of the Adult Brain Dead Potential Organ and Tissue Donor (accessed 2 March 2016)
Youn TS, Greer DM. Brain death and management of a potential organ donor in the intensive care unit. Critical Care Clinics. 2014 Oct;30(4):813-31. doi:10.1016/j.ccc.2014.06.010
Piazza O, Scarpati G, Rispoli F, et al. Terlipressin in brain-death donors. Clinical Transplantation. 2012;26(6): E571-575. doi:10.1111/ctr.12038
Erdoğan A. Donor Care in Intensiva Care Unit. Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi.2013; 4(3): 136-139.
Connor JP, Raife T, Medow JE. Outcomes of red blood cell transfu sions prescribed in organ donors by the Digital Intern, an electronic decision support algorithm. Transfusion. 2018; 58(2): 366–371. doi:10.1111/trf.14424
